Immunologist Derya Unutmaz used GPT-5 Pro to decode complex T cell behavior that had stalled for three years. The model identified specific patterns in cellular interactions that escaped human analysis. This breakthrough accelerates research into cancer and autoimmune diseases. Practitioners can now leverage advanced reasoning to bypass long-term biological bottlenecks in drug discovery.